Dürst M - Search Results

1

[HPV infection and cervical carcinoma--epidemiology, detection and immunology].

Schneider A, Dürst M, Kaufmann AM. Schneider A, et al. Among authors: durst m. Zentralbl Gynakol. 2001 Apr;123(4):179-85. doi: 10.1055/s-2001-14774. Zentralbl Gynakol. 2001. PMID: 11370524 Review. German.

2

Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.

Nindl I, Rindfleisch K, Lotz B, Schneider A, Dürst M. Nindl I, et al. Among authors: durst m. Int J Cancer. 1999 Jul 19;82(2):203-7. doi: 10.1002/(sici)1097-0215(19990719)82:2<203::aid-ijc9>3.0.co;2-9. Int J Cancer. 1999. PMID: 10389753

3

Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.

Schneider A, Hoyer H, Lotz B, Leistritza S, Kühne-Heid R, Nindl I, Müller B, Haerting J, Dürst M. Schneider A, et al. Among authors: durst m. Int J Cancer. 2000 Nov 20;89(6):529-34. Int J Cancer. 2000. PMID: 11102899

4

HPV induced cervical carcinogenesis: molecular basis and vaccine development.

Kaufmann AM, Backsch C, Schneider A, Dürst M. Kaufmann AM, et al. Among authors: durst m. Zentralbl Gynakol. 2002 Nov;124(11):511-24. doi: 10.1055/s-2002-39579. Zentralbl Gynakol. 2002. PMID: 12796844 Review.

5

HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination.

Kaufmann AM, Nieland J, Schinz M, Nonn M, Gabelsberger J, Meissner H, Müller RT, Jochmus I, Gissmann L, Schneider A, Dürst M. Kaufmann AM, et al. Among authors: durst m. Int J Cancer. 2001 Apr 15;92(2):285-93. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1181>3.0.co;2-q. Int J Cancer. 2001. PMID: 11291058

6

Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15.

Poignée M, Backsch C, Beer K, Jansen L, Wagenbach N, Stanbridge EJ, Kirchmayr R, Schneider A, Dürst M. Poignée M, et al. Among authors: durst m. Cancer Res. 2001 Oct 1;61(19):7118-21. Cancer Res. 2001. PMID: 11585743

7

Identification of novel molecular markers which correlate with HPV-induced tumor progression.

Nees M, van Wijngaarden E, Bakos E, Schneider A, Dürst M. Nees M, et al. Among authors: durst m. Oncogene. 1998 May 14;16(19):2447-58. doi: 10.1038/sj.onc.1201785. Oncogene. 1998. PMID: 9627111

8

Cervical cancer, HPV 16 E6, variant genotypes, and serology.

Nindl I, Rindfleisch K, Teller K, Schneider A, Dürst M. Nindl I, et al. Among authors: durst m. Lancet. 1999 Jan 9;353(9147):152. doi: 10.1016/S0140-6736(05)76193-6. Lancet. 1999. PMID: 10023929 No abstract available.

9

p53 mutations are rare events in recurrent cervical cancer.

Denk C, Butz K, Schneider A, Dürst M, Hoppe-Seyler F. Denk C, et al. Among authors: durst m. J Mol Med (Berl). 2001 Jun;79(5-6):283-8. doi: 10.1007/s001090100191. J Mol Med (Berl). 2001. PMID: 11485021

10

Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization.

Dürst M, Glitz D, Schneider A, zur Hausen H. Dürst M, et al. Virology. 1992 Jul;189(1):132-40. doi: 10.1016/0042-6822(92)90688-l. Virology. 1992. PMID: 1318602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters